Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07188896 |
| Title | A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC) |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Brian Rini |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Georgetown University | RECRUITING | Washington D.C. | District of Columbia | 20057 | United States | Details |
| University of North Carolina at Chapel Hill | RECRUITING | Chapel Hill | North Carolina | 27599 | United States | Details |
| Penn State Cancer Institute | RECRUITING | Hershey | Pennsylvania | 17033 | United States | Details |
| Vanderbilt-Ingram Cancer Center | RECRUITING | Nashville | Tennessee | 37232 | United States | Details |
| Froedtert and The Medical College of Wisconsin | RECRUITING | Milwaukee | Wisconsin | 53226 | United States | Details |